Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Genpharmasec Ltd
Genpharmasec Ltd

Genpharmasec Ltd Share Price

  • Sector: Trading (Small Cap)
  • Volume: 11,98,633
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1.38
₹-0.05 (-3.50%)
1.36Low
Today’s Performance
1.45High
1.36Low
52 Week’s Performance
4.32High

bt_logoStock Performance

  • 1 Day-3.50%
  • 1 Week-9.21%
  • 1 Month-9.21%
  • 3 Months-28.13%
  • 6 Months-33.97%
  • 1 Year-57.67%
  • 3 Years-17.64%
  • 5 Years-29.48%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.75
  • 52-Week Low (₹)1.36
  • 52-Week High (₹)4.32
  • Price-to-Book (X)*1.16
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*138.00
  • Earnings Per Share (₹)0.01
  • Market Cap (₹ Cr.)*76.41
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
View more

bt_logoFAQ's

What was Genpharmasec Ltd share price previously?
Genpharmasec Ltd share price was down by -3.50% from the previous closing price of ₹1.43.
Who are peers of Genpharmasec Ltd?
The peers of Genpharmasec Ltd are Adani Enterprises Ltd, Premier Energies Ltd, Aegis Logistics Ltd, Redington Ltd, Cello World Ltd, Honasa Consumer Ltd, MMTC Ltd.
Who is/are the promoter/promoters of Genpharmasec Ltd?
The promotor/promotors of Genpharmasec Ltd are Rajesh Sadhwani, Sneha Sadhwani, Siddhesh Shankar Shende, Mayur Bharatbhai Bhatt, Sachin Aphandkar, Mr. Sohan Chaturvedi, Hardik Makwana.
What has been 52-week high of Genpharmasec Ltd stocks?
The highest price of Genpharmasec Ltd stock is ₹4.32 in the last 52-week.
What is the share price of Genpharmasec Ltd (GENPHARMA) today on BSE?
As on Dec 05, 2025 Genpharmasec Ltd (GENPHARMA)’s share price on BSE is Rs 1.38
What is the market cap of Genpharmasec Ltd (GENPHARMA)?
The current market capitalisation of Genpharmasec Ltd (GENPHARMA) is 76.41 crores
What is Genpharmasec Ltd Share symbol?
The symbol of Genpharmasec Ltd is .
What is the PE ratio of Genpharmasec Ltd (GENPHARMA)?
The current PE ratio of Genpharmasec Ltd (GENPHARMA) is 138.00.
What is the PB ratio of Genpharmasec Ltd (GENPHARMA)?
The current PB ratio of Genpharmasec Ltd (GENPHARMA) is 1.16.
Today’s High & Low share prices of Genpharmasec Ltd (GENPHARMA) on BSE?
Today, the share price of Genpharmasec Ltd (GENPHARMA) on BSE touched a high of Rs 1.45 and a low of Rs 1.36
What price did Genpharmasec Ltd (GENPHARMA) shares open on the BSE today?
On BSE, the share price of Genpharmasec Ltd (GENPHARMA) opened at Rs 1.45
What is the 52-week high of Genpharmasec Ltd (GENPHARMA)?
The 52-week high price of Genpharmasec Ltd (GENPHARMA) is Rs 4.32
What is the 52-week low of Genpharmasec Ltd (GENPHARMA)?
The 52-week low price of Genpharmasec Ltd (GENPHARMA) is Rs 1.36

bt_logoAbout Genpharmasec

Genpharmasec Ltd, incorporated in the year 1992, has its registered office in Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East), Mumbai, Maharashtra, 400101. The main industry in which Genpharmasec Ltd operates is Trading.

Auditor/Auditors for Genpharmasec Ltd is/are Abhishek S Tiwari & Associates. In the main management, is chairman and Hardik Makwana is the company secretary for Genpharmasec Ltd.

  • RS
    Rajesh SadhwaniNon-Executive & Non-Independent Director
  • SS
    Sneha SadhwaniNon-Executive & Non-Independent Director
  • SSS
    Siddhesh Shankar ShendeIndependent Non Exe. Director
  • MBB
    Mayur Bharatbhai BhattIndependent Director
  • SA
    Sachin AphandkarIndependent Director
  • MSC
    Mr. Sohan ChaturvediWhole Time Director & Chief Financial Officer
  • HM
    Hardik MakwanaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.